Fig. 3From: Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trialPattern of Framingham mean score and risks for diabetes related complications in the trial with ascorbic acid arm and acetylsalicylic acid arm versus control arm (n = 422). Control Arm (metformin + Placebo) n = 142, Parallel Arm I: metformin + Ascorbic acid 500 mg OD: n = 139, Parallel Arm II: metformin + acetylsalicylic acid 100 mg OD: n = 141, RDiaC: Risk for diabetes related complications, *p < 0.05, **p < 0.01 independent-samples t test: comparison between interventional arms (I & II) versus Control arm, ‡ p < 0.01 independent-samples t test: comparison Parallel arm I versus Parallel arm IIBack to article page